Exact Mass: 456.00874359999995
Exact Mass Matches: 456.00874359999995
Found 31 metabolites which its exact mass value is equals to given mass value 456.00874359999995,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
6-(Dibromomethylene)testosterone
C20H26Br2O2 (456.02994160000003)
Selumetinib
C17H15BrClFN4O3 (456.00000220000004)
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EE - Mitogen-activated protein kinase (mek) inhibitors C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C69145 - Mitogen-Activated Protein Kinase Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor Selumetinib (AZD6244) is selective, non-ATP-competitive oral MEK1/2 inhibitor, with an IC50 of 14 nM for MEK1. Selumetinib (AZD6244) inhibits ERK1/2 phosphorylation.
CAY10561
C22H15Cl2FN4O2 (456.05560419999995)
Methyl 3-iodo-1-tosyl-1H-pyrrolo[2,3-b]pyridine-4-carboxylate
C16H13IN2O4S (455.96407680000004)
(2,4-Dichlorobenzyl)triphenylphosphonium Chloride
C25H20Cl3P (456.03681400000005)
2,6-dichlorobenzyl triphenylphosphonium chloride
C25H20Cl3P (456.03681400000005)
3,3,5,5-tetrakis(trifluoromethyl)benzhydrol
C17H8F12O (456.03835019999997)
Vinyltriethylsilane(hexafluoroacetylacetonate)silver(I)
Gdc-0623
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C69145 - Mitogen-Activated Protein Kinase Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor
Selumetinib
C17H15BrClFN4O3 (456.00000220000004)
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EE - Mitogen-activated protein kinase (mek) inhibitors C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C69145 - Mitogen-Activated Protein Kinase Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor Selumetinib (AZD6244) is selective, non-ATP-competitive oral MEK1/2 inhibitor, with an IC50 of 14 nM for MEK1. Selumetinib (AZD6244) inhibits ERK1/2 phosphorylation.
3-chloro-N-[3-(furan-2-ylmethylcarbamoyl)-5,6-dihydro-4H-cyclopenta[b]thiophen-2-yl]-1-benzothiophene-2-carboxamide
7-Methyl-7,8-dihydroguanosine-5-diphosphate(3-)
C11H16N5O11P2-3 (456.03215459999996)
7-Hydroxy-8-[(naphthalen-1-yl)diazenyl]naphthalene-1,3-disulfonate
7-Methyl-7,8-dihydroguanosine-5-diphosphate(3-)
C11H16N5O11P2 (456.03215459999996)
An organophosphate oxoanion obtained by deprotonation of the diphosphate OH groups of 7-methyl-7,8-dihydroguanosine-5-diphosphate.
(1r,4s,5r,6r,8r,9r,11r,14s,15r,18r,22r)-5,8,22-trihydroxy-19,20,23-trithia-3,13-diazaheptacyclo[13.5.1.1⁶,¹¹.1¹⁴,¹⁸.0¹,¹³.0³,¹¹.0⁴,⁹]tricosane-2,12,16-trione
C18H20N2O6S3 (456.04834600000004)
5,8,22-trihydroxy-19,20,23-trithia-3,13-diazaheptacyclo[13.5.1.1⁶,¹¹.1¹⁴,¹⁸.0¹,¹³.0³,¹¹.0⁴,⁹]tricosane-2,12,16-trione
C18H20N2O6S3 (456.04834600000004)
6,6',8,8'-tetrahydroxy-3'-(methoxycarbonyl)-1,1'-dioxo-[7,7'-biisochromene]-3-carboxylic acid
C21H12O12 (456.03287520000003)
(1s,4r,5s,6s,8s,9s,11s,14r,15s,18s,22s)-5,8,22-trihydroxy-19,20,23-trithia-3,13-diazaheptacyclo[13.5.1.1⁶,¹¹.1¹⁴,¹⁸.0¹,¹³.0³,¹¹.0⁴,⁹]tricosane-2,12,16-trione
C18H20N2O6S3 (456.04834600000004)